The FDA approved Nexium, Astra's top seller and the world's second-biggest prescription medicine, in two forms -- a delayed response capsule and a liquid -- it said in a statement.
ZURICH (Reuters) - AstraZeneca Plc's Nexium drug has been approved in the United States for treating excess stomach acid in children aged 1 to 11, the Food and Drug Administration (FDA) said on Thursday.
The FDA approved Nexium, Astra's top seller and the world's second-biggest prescription medicine, in two forms -- a delayed response capsule and a liquid -- it said in a statement.
It was approved in a dose of 10 milligrams, or 20mg daily, for children aged between 1 and 11, half the dosage for patients aged 12 to 17.
(Reporting by Sam Cage; Editing by David Holmes)
!ADVERTISEMENT!
